Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Top FDA Officials Warn About Non-Vetted Pharmacogenetic Tests After Latest 23andMe Approval

Nov 01 2018

DNA

Related Content

US FDA Implements 'Firm-Based' Regulatory Approach To DTC Genetic Health Risk Tests

Nov 07 2017

Digital Health, Diagnostic Focus Included In FDA Commissioner's 2018 Strategy

Jan 12 2018

FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans

May 17 2010

FDA Comes Down Hard On 23andMe, Putting Consumer-Directed Genetic Testing On Notice

Nov 25 2013

Related Companies

23andMe, Inc.

Additional Topics

United States Approvals Safety Regulation In Vitro Diagnostics Medical Device

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window